MYC and B-cell chronic lymphocytic leukemia: In particular, recent multi‐omic studies in CLL identified MYC activity as one of the main features associated with morbidity, either within the chronic phase [95] or during the evolution to high‐grade lymphoma [96] (a process known as Richter transformation).